App-Quantinova.ai

Effect of timing of vitamin B12 supplementation in patients receiving pemetrexed for treatment of advanced non-squamous non-small cell lung cancer or malignant pleural mesothelioma.

Zachary Schlei - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Cyanocobalamin

A consolidated screening tool for supportive oncology needs and distress.

Christine B. Weldon - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Preference among non-white cancer patients for mobile devices and social media to learn about supportive services.

Jun J. Mao - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Integrative oncology consultations at a comprehensive cancer center: Analysis of patient reported outcomes.

Gabriel Lopez - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Evaluating the appropriateness of granulocyte colony-stimulating factor (G-CSF) use in patients (pts) receiving myelosuppressive chemotherapy by febrile neutropenia (FN) risk level.

Hassam Baig - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Filgrastim

The role of limb hypothermia in preventing paclitaxel-induced peripheral neuropathy.

Raghav Sundar - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Paclitaxel

A complementary care program for improving quality of life of cancer patients during adjuvant radiotherapy and/or chemotherapy or outpatient aftercare.

Martin Domnick - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Persistent postmastectomy pain syndrome and posttraumatic stress disorder among breast cancer survivors (ORTHUS study): A study of the palliative care working committee of the Turkish Oncology Group (TOG).

Ali Alkan - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

The effect of early palliative care on end-of-life ICU utilization and ICU course in patients with advanced cancer.

Andrew Michael Romano - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

A RARE FORM OF CANCER, THYROID CANCERS INCREASING IN YOUNG ADOLESCENTS.

Emel Cabi Unal - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

A new agent, liposomal cisplatin, in the treatment of relapsed or metastatic childhood solid tumors: Toxicity and clinical effectiveness.

Nurdan Tacyildiz - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Paclitaxel

The role and optimal duration of adjuvant imatinib therapy in primary GIST patients.

Peter Arkhiri - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Imatinib

Head and neck synovial sarcomas: Clinical characteristics and survival.

Vancheswaran Gopalakrishnan - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Clinicopathologic characteristics of patients with recurrent or metastatic synovial sarcoma.

Ozturk Ates - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Well differentiated / dedifferentiated liposarcoma: Are patients at risk of developing a second cancer?

Eric E. Jung - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Treatment of bone and soft-tissue sarcoma patients in Japan: The distribution of patients and medical specialties by cancer topography and treatment modality.

Makoto Endo - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Solid malignancies

N/A

Vinorelbine-based chemotherapy in metastatic epithelioid sarcoma.

Camille Tlemsani - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Vinorelbine

ADAM9 to enhance CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis.

Kuo-Liang Chiu - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Analysis of delayed reconstruction and tumor relapse in breast cancer.

Facundo Alberti - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Elevated circulating NKT cells in penile carcinoma.

Felipe Da Silva Marinho - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Filters

41730 Abstracts